LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA

Genome Biol. 2024 Jun 14;25(1):157. doi: 10.1186/s13059-024-03262-2.

Abstract

Methylation-based liquid biopsies show promises in detecting cancer using circulating cell-free DNA; however, current limitations impede clinical application. Most assays necessitate substantial DNA inputs, posing challenges. Additionally, underrepresented tumor DNA fragments may go undetected during exponential amplification steps of traditional sequencing methods. Here, we report linear amplification-based bisulfite sequencing (LABS), enabling linear amplification of bisulfite-treated DNA fragments in a genome-wide, unbiased fashion, detecting cancer abnormalities with sub-nanogram inputs. Applying LABS to 100 patient samples revealed cancer-specific patterns, copy number alterations, and enhanced cancer detection accuracy by identifying tissue-of-origin and immune cell composition.

Keywords: Bisulfite sequencing; Cancer detection; Cell-free DNA; Linear amplification; Low-input DNA.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell-Free Nucleic Acids
  • Circulating Tumor DNA / genetics
  • DNA Copy Number Variations
  • DNA Methylation*
  • DNA, Neoplasm / genetics
  • Humans
  • Neoplasms* / genetics
  • Nucleic Acid Amplification Techniques / methods
  • Sequence Analysis, DNA* / methods
  • Sulfites*

Substances

  • Sulfites
  • Cell-Free Nucleic Acids
  • hydrogen sulfite
  • DNA, Neoplasm
  • Circulating Tumor DNA